Chat about Int.biotech. accounts information. See how Int.biotech. is performing financially.

Int.biotech. Accounts Summary


Date of Accounts 20232022202120212020
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement30-08-202330-08-202231-08-202130-08-202131-08-2020
Revenue0.861.111.101.101.13
Operating Profit / Loss-2.51-2.11-2.37-2.37-1.79
Net Interest-1.24-0.66-0.22-0.22-0.26
Pre Tax Profit-3.75-2.78-2.59-2.59-2.06
Post Tax Profit-3.87-2.93-2.75-2.75-2.23
Profit for the Period-3.87-2.93-2.75-2.75-2.22
Equity Holders of Parent Company-3.87-2.93-2.75-2.75-2.22
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-9.53p-7.13p-6.80p-6.80p-5.79p
Earnings per Share (Diluted)-9.53p-7.13p-6.80p-6.80p-5.79p
Earnings per Share (Adjusted)-9.53p-7.13p-6.80p-6.80p-5.79p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-9.53p-7.13p-6.80p-6.80p-5.79p
Earnings per Share (Diluted)-9.53p-7.13p-6.80p-6.80p-5.79p
Earnings per Share (Adjusted)-9.53p-7.13p-6.80p-6.80p-5.79p
      
Dividend per Share28.20p31.40p28.40p28.40p24.80p
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet30-08-202330-08-202231-08-202130-08-202131-08-2020
Non-Current Assets     
Intangible Assetsn/an/an/an/an/a
Property, Plant and Equipmentn/an/an/an/an/a
Investments301.90313.43345.34345.34302.22
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets301.90313.43345.34345.34302.22
      
Current Assets     
Inventoriesn/an/an/an/an/a
Trade and Other Receivables2.9713.490.940.940.16
Cash at Bank and in Handn/an/a1.561.560.32
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/an/an/an/a
Total Current Assets2.9713.492.502.500.49
      
Other Assetsn/an/an/an/an/a
Total Assets304.87326.92347.83347.83302.71
      
Current Liabilities     
Borrowings32.4739.9821.8721.8718.10
Other Current Liabilities2.082.052.192.190.71
Total Current Liabilities34.5542.0324.0624.0618.81
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowingsn/an/an/an/an/a
Provisionsn/an/an/an/an/a
Other Non-Current Liabilitiesn/an/an/an/an/a
Total Non-Current Liabilitiesn/an/an/an/an/a
      
Net Assets270.32284.89323.77323.77283.90
      
Capital and Reserves     
Share Capital10.3510.3510.3510.3510.34
Share Premium Account29.8729.8729.8729.8720.43
Other Reserves280.63291.33327.29327.29294.11
Retained Earnings-50.53-46.66-43.73-43.73-40.98
Shareholders Funds270.32284.89323.77323.77283.90
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity270.32284.89323.77323.77283.90
      
 30-08-202330-08-202231-08-202130-08-202131-08-2020
Operating Margin-290.38%-189.94%-214.66%-214.66%-158.29%
Return on Capital Employedn/a%n/a%n/a%n/a%n/a%
Dividend Cover-0.34-0.23-0.24-0.24-0.23
Dividend Yield4.404.803.903.903.40
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%11.35%n/a%-9.55%-12.68%
Net Asset Value per Share692.52p729.86p784.75p829.48p688.10p